Clorox Q2 net sales fall 1% to $1.67 billion; diluted EPS down 16%, outlook kept
Clorox reported second-quarter fiscal 2026 results for the period ended December 31, 2025, with net sales down 1% to $1.67 billion and diluted EPS down 16% to $1.29. The company kept its full-year outlook but said results are tracking toward the lower end of the range because of order fulfillment challenges, an inventory drawdown, and higher costs.
Key points
- Net sales fell 1% to $1.67 billion; organic sales also fell 1%, driven by lower consumption.
- Diluted EPS fell 16% to $1.29 from $1.54; adjusted EPS fell 10% to $1.39 from $1.55.
- Full-year fiscal 2026 guidance was maintained: diluted EPS of $5.60 to $5.95 and adjusted EPS of $5.95 to $6.30, both at the lower end of the range.
- Household segment adjusted EBIT fell 54%; International segment adjusted EBIT rose 48%.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 03, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.